| Nucleic Acids Research | Pages |
Targeting of nucleic acid junctions: addressing to a branch point an oligodeoxynucleotide conjugated with an intercalator
Introduction
Materials And Methods
1-[3-O-acetyl-2-deoxy-5-O-(4,4[prime]-dimethoxytrityl)-[beta]-d-pento-furanosyl]-5-methyl-4-(2,4,6- trimethylbenzene-sulfonyloxy)pyrimidin-2(1H)-one (2)
3[prime]-O-acetyl-2[prime]-deoxy-5[prime]-O-(4,4[prime]-dimethoxytrityl)-5-methyl-N4-(4-phenoxyphenyl)cytidine (3)
2[prime]-deoxy-5[prime]-O-(4,4[prime]-dimethoxytrityl)-5-methyl-N4-(4-phen-oxyphenyl)cytidine (4)
2[prime]-deoxy-5-methyl-N4-(4-phenoxyphenyl)cytidine (5)
Phosphoramidite derivative 6
In vitro synthesis of 32P-labelled hok mRNA
RNase H cleavage assay
Results And Discussion
Synthesis of the building block
DNA TWJs and DNA duplexes
RNase H studies
References
Targeting of nucleic acid junctions: addressing to a branch point an oligodeoxynucleotide conjugated with an intercalator
ABSTRACT
INTRODUCTION
Selective control of gene function is currently becoming assessed using oligodeoxynucleotides (ODNs) targeted toward either DNA or RNA (1). The selectivity of such ODNs should be controlled by Watson-Crick base pairing interaction between the two complementary sequences. RNAs can be written as single strands, but because of self pairing, they show branched structures. A typical feature is a hairpin consisting of a double- stranded stem region bound to single-stranded regions at the foot of the stem. Francois et al. (2) found enhanced duplex stability due to coaxial stacking when single-stranded DNA was hybridized next to the stem to one of the sides of a DNA hairpin foot. Bruice and Lima (3) similarly reported about preferred binding of antisense DNA to Ha-ras mRNA stem-loop fragment using combinatorial screening. They found preferred 5[prime]-single strand binding to the 5[prime]-loop site allowing coaxial stacking between the hybridizing DNA and the stem. Another way of recognizing the structured nucleic acids could be hybridization to both sides of the foot of the stem by forming a three-way junction (TWJ). Leontis et al. (4) have studied the TWJ and their data showed that the TWJ could be stabilized when unpaired bulged bases were added to one of the strands at the branch point. Moreover, TWJ has been studied by NMR on complexes with two unpaired bases at the branch point and a preferred coaxial stacking interaction at the branch point was found (5,6). Cload and Schepartz (7) found that a TWJ-forming ODN was an inhibitor of Rev response element of human immunodeficiency virus genome. Even formation of a four-way junction has been reported by Cload et al. (8) as a possible way of recognizing RNA using tethered ODN.
To enhance the penetration of ODN into the cells, it could be an advantage to synthesize the ODN carrying hydrophobic (9,10) and lipophilic (11) moieties. Especially, it would be of interest to synthesize new ODNs with lipophilic conjugates which could improve both cell uptake and hybridization properties. The problem, however, is to find a proper way of increasing duplex stability using lipophilic moieties. Casale and Mclaughlin (12), studying the hybridization of double-stranded DNA, observed destabilization of the duplex when the modified ODN contained a polyaromatic hydrocarbon substituted at N2 on guanosine. We found it more promising to improve the hybridization properties by conjugating a lipophilic intercalating moiety to a junction region of nucleic acids. From thermal spectroscopy of TWJ in DNA, improved stabilization was found for the DNA TWJ when 2[prime]-deoxy-5-methyl-N4-(1-pyrenylmethyl)cytidine was inserted into the junction region of a TWJ-forming ODN which was hybridized across the foot of a hairpin (13). In this investigation we synthesize 2[prime]-deoxy-5-methyl-N4-(4-phenoxyphenyl)cytidine for incorporation into the TWJ.
MATERIALS AND METHODS
NMR spectra were recorded at 250 MHz for 1H-NMR, 62.9 MHz for 13C-NMR and 101.3 MHz for 31P-NMR on a Bruker AC-250FT spectrometer; [delta]-values are in p.p.m. relative to tetramethylsilane as internal standard (1H- NMR and 13C-NMR), relative to 85% H3PO4 as external standard in 31P-NMR. Positive FAB mass spectra were recorded on a Kratos MS 50 RF spectrometer. Analytical silica gel TLC was performed on Merck precoated 60 F254 plates. The silica gel (0.040-0.063 mm) used for column chromatography was purchased from Merck. Melting experiments were carried out on a Perkin-Elmer UV-VIS spectrometer Lamda 2 fitted with a PTP-6 Peltier temperature programming element. The absorbance of 260 nm was increased by 1°C/min in a 1 cm cuvette. DNA syntheses were performed on a Pharmacia Gene Assembler Special® DNA synthesizer. Desalting of oligonucleotides was accomplished using disposable NAP-10 columns (Pharmacia).
1-[3-O-acetyl-2-deoxy-5-O-(4,4[prime]-dimethoxytrityl)-[beta]-d-pento-furanosyl]-5-methyl-4-(2,4,6- trimethylbenzene-sulfonyloxy)pyrimidin-2(1H)-one (2)
A solution of 2,4,6-trimethylbenzenesulfonyl chloride (3.63 g, 16.6 mmol) in dry CH2Cl2 (10 ml freshly distilled from CaH2) was added to a vigorously stirred mixture of 3[prime]-O-acetyl-5[prime]-O-(4,4[prime]-dimethoxytrityl)thymidine (1; 4.86 g, 8.3 mmol). Freshly distilled Et3N (3.2 g, 32 mmol), and DMAP (0.1 g) in dry CH2Cl2 (30 ml) were added at room temperature. The stirring was continued for 20 h and the resulting mixture was concentrated at 30°C in vacuo to 10 ml and the resulting solution was purified by chromatography on a silica gel column eluted with CH2Cl2 to afford 2 (5.48 g, 86%); 1H-NMR (CDCl3) [delta] 1.59 (s, 3H, CH3), 2.04 (s, 3H, CH3 mesityl), 2.29 (s, 3H, Ac), 2.33 (m, 2H, 2[prime]-H), 2.74 (s, 6H, 2 × CH3 mesityl) 3.45 (m, 2H, 5[prime]-H), 3.78 (s, 6H, 2 × OCH3), 4.19 (d, 1H, J = 2.4 Hz, 4[prime]-H), 5.37 (dd, 1H, J = 2.4, 4.8 Hz, 3[prime]-H), 6.22 (dd, 1H, J = 5.8, 7.6 Hz, 1[prime]-H), 6.84 (d, 4H,J = 8.8 Hz, arom), 6.98 (s, 2H, arom), 7.11-7.63 (m, 9H, arom), 8.04 (s, 1H, 6-H). 13C-NMR (CDCl3) [delta] 11.97 (CH3), 21.21 (CH3), 21.44 (Ac), 23.04 (2 × CH3), 39.67 (C-2[prime]), 55.57 (2 × OMe), 63.60 (C-5[prime]), 75.00 (C-3[prime]), 84.96 (C-1[prime]), 87.24 (C-4[prime]), 87.49 (trityl), 104.41 (C-5), 113.67, 127.53, 128.35, 130.29, 130.34, 130.46, 132.12, 135.52, 141.02, 143.42, 144.43, 144.50, 159.13 (arom), 135.48 (C-6), 153.87 (C-2), 166.53 (C-4), 170.59 (CH3 CO). MS (FAB) (CHCl3 + 3-nitrobenzylalcohol) m/z: 769 (M + H+).
3[prime]-O-acetyl-2[prime]-deoxy-5[prime]-O-(4,4[prime]-dimethoxytrityl)-5-methyl-N4-(4-phenoxyphenyl)cytidine (3)
Compound 2 (1.56 g, 2.03 mmol) was allowed to react with 4-phenoxyaniline (0.9 mmol) in dry tetrahydrofuran (20 ml). N,N-diisopropylethylamine (0.6 ml) was added and the reaction mixture was refluxed for 36 h. The solvent was removed in vacuo and the resulting gum was purified by silica gel chromatography with 0-1% MeOH/CH2Cl2 to give 3 (1.11 g, 73%); 1H-NMR (CDCl3) [delta] 1.61 (s, 3H, CH3), 2.02 (s, 3H, Ac), 2.32 (m, 1H, 2[prime]-H), 2.56 (m, 1H, 2[prime]-H), 3.47 (m, 2H, 5[prime]-H), 3.74 (s, 6H, 2 × OMe), 4.14 (m, 1H, 4[prime]-H), 5.40 (m, 1H, 3[prime]-H), 6.49 (m, 1H, 1[prime]-H), 6.60-7.65 (m, 23H, NH, arom), 7.74 (s, 1H, 6-H). 13C-NMR (CDCl3) [delta] 12.54 (CH3), 20.68 (Ac), 38.67 (C-2[prime]), 54.95(2 × OMe), 63.42 (C-5[prime]), 75.01 (C-3[prime]), 83.67 (C-1[prime]), 85.49 (C-4[prime]), 86.71 (trityl), 102.56 (C-5), 113.05-133.09 (arom), 135.17 (C-6), 137.72-153.37 (arom), 155.45 (C-2), 157.20, 158.45 (arom), 161.20 (C-4), 170.16 (CH3CO). MS (FAB) (CHCl3 + 3-nitrobenzyl-alcohol) m/z: 754 (M + H+).
2[prime]-deoxy-5[prime]-O-(4,4[prime]-dimethoxytrityl)-5-methyl-N4-(4-phen-oxyphenyl)cytidine (4)
To a stirred solution of 3 (1.13 g, 1.5 mmol) in methanol (30 ml) was added MeONa (810 mg, 15 mmol) in methanol (10 ml) at room temperature and the solution was stirred for 1 h. NH4Cl (802 mg, 15 mmol) was added and the reaction mixture was stirred for 30 min. After removing the solvent in vacuo, the residue was chromatographed on a silica gel column with 0-5% MeOH/CH2Cl2 affording 4 in 100% yield (1.06 g); 1H-NMR (CDCl3) [delta] 1.60 (s, 3H, CH3), 2.22 (m, 1H, 2[prime]-H), 2.59 (m, 1H, 2[prime]-H), 3.45 (m, 2H, 5[prime]-H), 3.75 (s, 6H, 2 × OMe), 3.86 (m, 1H, 3[prime]-H), 4.12 (m, 1H, 4[prime]-H), 4.55 (broad s, 1H, OH), 6.41 (m, 1H, 1[prime]-H), 6.69-7.64 (m, 23H, NH, arom), 7.81 (s, 1H, 6-H). 13C-NMR (CDCl3) [delta] 12.65 (CH3), 42.01 (C-2[prime]), 55.10 (2 × OMe), 63.64 (C-5[prime]), 71.80 (C-3[prime]), 86.02, 86.15 (C-1[prime], C-4[prime]), 86.58 (trityl), 102.15 (C-5), 113.14-133.19 (arom), 135.51 (C-6), 135.56-153.49 (arom), 155.80 (C-2), 157.38, 158.50 (arom), 161.24 (C-4). MS (FAB) (CHCl3 + 3-nitrobenzylalcohol) m/z: 708 (M + H+).
2[prime]-deoxy-5-methyl-N4-(4-phenoxyphenyl)cytidine (5)
Detritylation solution (Cl3CCOOH/C2H4Cl2, Cruachem) (8 ml) was added to a stirred solution of 4 (500 mg, 0.70 mmol) in C2H4Cl2 (15 ml). The reaction mixture was stirred for 5 min at room temperature. The solvent was removed in vacuo and the resulting brownish-red residue was purified on a silica gel column using 0-15% MeOH/CH2Cl2 yielding 5 (262 mg, 92%) as a yellowish-white foam; 1H-NMR (DMSO-d6) [delta] 1.98-2.03 (m, 1H, 2[prime]-H), 2.05 (s, 3H, CH3), 2.10-2.12 (m, 1H, 2[prime]-H), 3.40-3.52(m, 2H, 5[prime]-H), 3.55-3.79 (m, 3H, 3[prime]-H, 4[prime]-H, OH), 4.25 (broad s, 1H, OH), 6.16-6.21 (m, 1H, 1[prime]-H), 7.00-7.42 (m, 6H, NH, arom), 7.00-7.81 (m, 4H, arom), 8.33 (s, 1H, 6-H). 13C-NMR (DMSO-d6) [delta] 13.45 (CH3), 38.88 (C-2[prime]), 61.19 (C-5[prime]), 70.20 (C-3[prime]), 84.86 (C-1[prime]), 87.28 (C-4[prime]), 102.29 (C-5), 118.12-134.65 (arom), 138.92 (C-6), 154.80 (C-2), 162.24 (C-4). MS (FAB) (CHCl3 + 3-nitrobenzylalcohol) m/z: 410 (M + H+). Found: C, 64.49; H, 5.68; N, 10.23%. C22H23N3O5 requires C, 64.54; H, 5.66; N, 10.26%.
Phosphoramidite derivative 6
Compound 4 (600 mg, 0.85 mmol) was coevaporated with dry MeCN and dissolved in a mixture of N,N-diisopropylethylamine (0.8 ml) and dry CH2Cl2 (2.5 ml). 2-Cyanoethyl-N,N-diisopropylchlorophosphoramidite (0.35 ml, 1.53 mmol) was added dropwise under argon. The reaction mixture was stirred at room temperature for 1.5 h and quenched by addition of 2 ml methanol. EtOAc and CH2Cl2 (100 ml) were added to the reaction mixture followed by washing with saturated aqueous NaHCO3 (3 × 30 ml). The organic layer was dried (Na2SO4) and evaporated in vacuo. The product was purified by silica gel column chromatography (EtOAc/CH2Cl2/Et3N, 15:80:5). The resulting gum was dissolved in 2 ml of dry toluene and the solution was added dropwise to 200 ml cold petroleum ether with stirring. The solid product was filtered off to give a yellowish-white compound 6, yield 757 mg (83%); 31P-NMR (CDCl3) [delta] 147.96 and 148.70. MS (FAB) (CHCl3 + 3-nitrobenzylalcohol) m/z: 912 (M + H+).
In vitro synthesis of 32P-labelled hok mRNA
In vitro hok transcripts were synthesized using T7 RNA polymerase (Promega) and a DNA template generated by PCR according to Franch and Gerdes (14).
RNase H cleavage assay
The DNA oligo:RNase H cleavage assays were conducted according to Franch et al. (15,16). A sample of 20 fmol uniformly 32P-labelled hok mRNA was incubated in 1× TMK-glutamate buffer [20 mM Tris-acetate (pH 7.5) 10 mM Mg-acetate and 200 mM K-glutamate] supplemented with 1 mM DTT for 3 min at 37°C to equilibrate RNA folding. DNA oligo (10 pmol) and RNase H (1 U; Gibco) were added to give a total reaction volume of 10 µl. The reaction was incubated for an additional 30 min at 37°C, and stopped by addition of Formamid Dye (FD) and withdrawal to 0°C. In the control reaction, the oligo was omitted. Samples were heated at 80°C for 3 min prior to separation on a 5.5% acrylamide gel, 1× TBE, containing 8 M urea.
RESULTS AND DISCUSSION
Synthesis of the building block
The protected nucleoside 3[prime]-O-acetyl-2[prime]-deoxy-5[prime]-O-(dimethoxytrityl)thymidine (1) (13) was reacted overnight at room temperature with 2,4,6-trimethylbenzenesulfonyl chloride in the presence of triethylamine and 4-dimethylaminopyridine (DMAP) in dichloromethane to give the O4-thymidine derivative 2 in 86% yield after purification by column chromatography (Scheme 1). The N4-cytidine derivative 3 was synthesized in 73% yield by refluxing 4-phenoxyaniline with the O4-thymidine derivative 2 in tetrahydrofuran in the presence of N,N-diisopropylethylamine for 36 h followed by chromatographic column purification. The alternative triazole activation (13) by reaction of 1 with a triazole phosphorus oxychloride reagent was found insufficient in our hands for the reaction with an aromatic amine. Deacetylation of compound 3 was carried out with sodium methoxide in methanol for 1 h to give the free 3[prime]-OH nucleoside 4 in 100% yield. Subsequent deprotection using the detritylation solution Cl3CCOOH/C2H4Cl2 at room temperature for 5 min gave the deprotected N4-substituted cytidine derivative 5 in 92% yield. Phosphitylation of 4 to give 6 was achieved in 83% yield by reaction of 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite with the nucleoside 4 in the presence of N,N-diisopropylethylamine and dichloromethane for 2 h. The purity of the phosphoramidite 6 was 100% according to 31P-NMR spectroscopy.
Scheme 1. Figure 1. ODNs used for hybridization studies. X is the diphenyl ether conjugated nucleoside 5. According to the phosphoramidite methodology (17) both modified and unmodified ODNs were synthesized on a Pharmacia Gene Assembler Special DNA synthesizer in a 0.2 µmol scale. The coupling efficiencies for the modified phosphoramidite 6 (6 min couplings) and commercial ones (2 min couplings) were 99%. The efficiency of each coupling step was monitored by release of dimethoxytrityl cation after each step. Removal from the solid support and deprotection was carried out at room temperature for 4 days in 25% ammonia. All ODNs were desalted using the Pharmacia NAP-10 columns. The concentration of the ODNs strands was quantitated by UV absorption at 260 nm using the molar extinction coefficients for the modified nucleoside 5 and for the unmodified ones (18). The ratio of the molar extinction coefficient for 2-deoxycytidine:5 was 8.7:1 in methanol at 260 nm.
DNA TWJs and DNA duplexes
The hybridization properties of the modified ODNs (Fig.
For our investigations of the effect of a conjugated intercalator at the TWJ branch point, we selected the target A (Fig.
From Table 1, it can be seen that the TWJ (Duplex type I) with the modified ODN (X-17mer) is more stabilized than the natural ones. We observed only a small difference in melting point ([Delta]Tm = 2.8°C) when a bulged C was inserted at the branch point while a large increase in melting temperature ([Delta]Tm = 9.0°C) was observed when the intercalating phenoxyphenyl conjugated cytidine was inserted. Also, we observed a positional effect of the insertion on the stability of the TWJ when the conjugated nucleoside 5 was inserted around the branch point. We observed Tm = 29.8°C ([Delta]Tm = 2.6°C) when X was bulged next to the branch point in the 3[prime]-end direction of the hairpin, and Tm = 31.8°C ([Delta]Tm = 4.6°C) when X was bulged next to the branch point in the other direction. This positional effect has previously been observed on insertion of 7 (13) and may be related to coaxial stacking since a determining factor for this could be sequence of the base pairs immediately flanking the junction region (19). Entry 4 in Table 1 confirms an expected lower stability of a duplex corresponding to one of the arms of the TWJ and this excludes Entry 3 to be of Duplex type II with two long dangling ends.
Table 1. In Table 2, the thermal melting data are shown for a duplex corresponding to Duplex type I except that the loop stem parthas been deleted from target A. The data show that the bulged Cat the former branch point (Entry 6) destabilize the duplex([Delta]Tm = -9.2°C) and this is in good agreement with the previously reported results (20,21), while the insertion of intercalating 5 (Entry 7) gave less destabilization of the duplex ([Delta]Tm = -6.6°C). Table 2. It has been reported (22,23) that a TWJ, without bulged nucleotides in the junction region, has a trigonal arrangement of the three intact helical arms. In this case, base pair stacking across the junction is not possible. There are six base pair helix ends in this type of TWJ compared with two helical ends in a duplex with the same number of base pairs, and this may explain the lower stability of the TWJ when compared with the corresponding duplex. It has been shown that unpaired bases at the point of the branch changes the trigonal arrangement into an asymmetrical structure which is consistent with a stacking between two of the arms at the branch point, and an inclined orientation of the third (non-stacked) arm to the other two (stacked) arms (23,24). One of the complementary strands of this third helical arm contains the strand that has the extra bulged nucleotides. For the latter TWJ there are still additional two helical ends compared with a non-branched two-stranded duplex structure. At first approximation the additional two helical ends in the branched structure would correspond to a decrease in the stacking interactions of a consecutive base pair in the middle of a helical duplex (24). For the TWJ (Type I, Entry 3) with diphenyl ether conjugated to an extra nucleotide, it is now assumed that the extra duplex stability is achieved by placing the large non-polar diphenyl ether as a stacking moiety covering the end of the inclined helical arm at the branch point. The stacking affinity of the diphenyl ether to the inclined helical arm is most likely enhanced because of the diphenyl ether hydrophobicity. The group of Kool (25) has investigated the aromatic stacking affinities of dangling C-nucleosides at the 5[prime]-ends of a self-complementary duplex. When thymine was replaced by pyrene as the base of the dangling nucleotide, the Tm of the duplex was raised by 16°C due to the better stacking ability of the pyrenes which were assumed to cover the ends of the duplex. Table 3. Another way to target a stem flank region is to use a short ODN (2) which hybridizes to only one of the flanks, in such a way that coaxial stacking to the loop is possible (see Duplex type III in Table 3). Again, we used the target A which for hybridization with 9mer, C-9mer, and X-9mer (Fig.
RNase H studies
From the above studies on the ODN duplexes one could think it also possible to stabilize the junction regions in DNA/RNA TWJs. From the literature it is known that antisense ODNs linked to an intercalating acridine derivative can improve translational inhibition of mRNAs, most likely by an RNase H dependent mechanism (26,27). We therefore found it is of interest to investigate how insertion of the nucleoside 5 or 7 (Scheme 2) into an ODN could influence the RNase H cleavage of an RNA at a junction region. The N4-pyren-1-ylmethylcytidine analog 7 (13) has previously been shown to stabilize an ODN TWJ and was of interest to be included in this study because it is always possible that different chemical modifications of the targeting ODNs can show variations in RNase H hydrolyses of the DNA-RNA hybrids (28).
Scheme 2. For our antisense studies we selected hok mRNA from plasmid R1 which has a well-defined secondary structure (Fig. Extension of the ODN from Entry 20 at the 5[prime] end with the conjugated pyrene nucleoside 7 resulted in an increased RNase H cleavage (Entry 25). However, it is not possible to tell whether this effect is due to intercalating effect of the pyrene ring or due to simple base pairing by replacing C-98 in the G-83:C-98 base pair with the modified nucleoside 7. In fact, an improved RNase H cleavage was also observed when the ODN from Entry 20 was extended with C at the 5[prime] end (Entry 23). Further extension of the latter ODN with 7 at the 5[prime] end gave even further improved RNase H cleavage (Entry 24). However, the intercalating effect should be considered important, since RNase H cleavage was completely absent when 5 was used instead of 7 (data not shown). Another interesting feature of the extended ODNs 23 and 24 was an increasing downstream hydrolysis of the hok mRNA on the 3[prime]-side of the stem-loop domain. This effect could be due to cleavage on the other side of the stem-loop region at the single-stranded RNA adjacent to the RNA-DNA duplex as reported by Lima and Crooke (30). Figure 2. hok mRNA from plasmid R1. Figure 3. RNase H cleavage of the 361 nucleotide hok mRNA from plasmid R1. (A) Effect of 7 or C when inserted in the middle of a short coaxially stacked ODN. (B) Using 7 or C for extending a short coaxially stacked ODN at the junction. (C) Insertion of 5 or C at the branch point of a TWJ. The Type I TWJ using hok mRNA was considered possible by using the complementary ODN to the sequence G-76 to A-82 tethered via 5, 7 or cytidine to the complementary ODN to the sequence C-99 to A-103. The effect of one or two deletions at the 5[prime] end of the latter ODN sequence was also investigated. Except for one case, all these tethered ODNs did not mediate any significant RNase H cleavage despite all having the same sequences as Entry 20, 23 or 25 at the upstream part of the hok mRNA. It is believed that the extra dangling tethered ODN due to steric interactions prevents a sufficiently high stability of the duplex, and is also influencing the RNase H cleavage. Only in one case, by using the conjugated diphenyl ether nucleoside 5 for tethering and with one deletion at the 5[prime] end, was significant RNase H activity observed (Entry 27). In this case, not only was significant RNase H activity observed, but the cleavage was also taking place on the upstream side of the hairpin of hok mRNA when compared with Entry 20. One can speculate why exactly one deletion at the 5[prime] end of the ODN is a prerequisite for RNase H cleavage. However, with this length of the ODN, coaxial stacking from the 5[prime] end of the targeting ODN to U-329 is possible and may induce the base pairings A-103:U-329 and C-104:G-328. In this way, a sufficiently long DNA-RNA duplex is established to accomplish RNase H hydrolysis at this side of the hairpin. In this work we have shown that conjugated intercalators at a DNA-DNA TWJ improve its stability as measured by its thermal denaturation. It is also clear that short ODNs can increase RNase H cleavage at the flanks of an RNA hairpin. For the conjugated ODNs the results are more ambiguous whether the RNase cleavage can be enhanced. Although a lot of work is needed in order to find the best type of conjugate and linker which again may depend on the specific target, we still think it possible to develop short and lipophilic conjugated ODNs for targeting junctions in RNA.
REFERENCES
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 17 Oct 1998
Copyright©Oxford University Press, 1998.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This Article ![]()
![]()
Abstract
![]()
Print PDF (112K)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (6)
![]()
Request Permissions ![]()
Commercial Re-use Guidelines
for Open Access NAR Content
![]()
Google Scholar ![]()
![]()
Articles by Ali, O. M.
![]()
Articles by Pedersen, E. B.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Ali, O. M.
![]()
Articles by Pedersen, E. B.
![]()
Social Bookmarking ![]()
![]()
What's this?